Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver disease

Hepatology

Volumn 23, Issue 6, 1996, Pages 1498-1506

  Saito, Hidetsugu ^a   Tada, Shinichiro ^a   Ebinuma, Hirotoshi ^a   Atsukawa, Kazuhiro ^a   Masuda, Tetsuya ^a   Inagaki, Yasutaka ^b   Tsuchimoto, Kanji ^c   Morizane, Toshio ^d   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

^b Nihon Kohkan Hospital   (Japan)

^c KITASATO INSTITUTE HOSPITAL   (Japan)

^d KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H2; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER CELL; PRIORITY JOURNAL;

EID: 0029989024     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008675170     Document Type: Article

References (11)

1. Mackay IR, Taft LJ, Cowling DC. Lupoid hepatitis. Lancet 1956;2:1323-1326.
2. Storch W. Immunopathology and human autoimmunity in chronic active hepatitis. Scand J Gastroenterol 1988;23:513-516.
3. Morizane T, Tsuchimoto K, lino A, Matsumura S, Saito H, Satoh I, Kumagai N, et al. Two different murine monoclonal antibodies B2 and H2 which are specific for human hepatocytes (in Japanese with English abstract). Kanzou (Acta Hepatologica Japonica) 1986;27:726-735.
4. Saito H, Morizane T, lino A, Tsuchimoto K, Hamada Y, Satoh I, Sawaguchi K, et al. Characterization of human liver-specific antigen 1 (HLSA 1) defined by the murine monoclonal antibody H2 (in Japanese with English abstract). Nippon Shoukakibyou Gakkai Zasshi (Jpn J Gastroenterol) 1987;84:675-683.
5. MacFarlane IG, Heagrty JE, McSorley CG, McFarlane BM, Williams R. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 1984;2:954-956.
6. McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 1986;3:196-205.
7. Hopf U, Meyer zum Buschenfelde KH, Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 1976;294:578-582.
8. Lee WM, Shelton LL, Galbraith RM. Antibodies to hepatocyte membrane antigens in chronic liver disease: detection by immunofluorescenee after Bouin's fixation. J Histochem Cytochem 1983;31:1246-1249.
9. Sheron N, Eddleston A. Autoimmune chronic active hepatitis. In: McIntyle N, et al., eds. Oxford textbook of clinical hepatology. New York: Oxford University Press, 1991:758-767.
10. Saito H, Morizane T, Watanabe T, Kagawa T, Miyaguchi S, Kumagai N, Tsuchiya M. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Int J Cancer 1991;48:291-296.
11. McDonell MW, Simon MN, Studier FW. Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels. J Mol Biol 1977;110:119-125.